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Edited by Jesus AvilaAbstract Serotonin 5-HT4 receptor isoforms are G protein-
coupled receptors (GPCRs) with distinct pharmacological prop-
erties and may represent a valuable target for the treatment of
many human disorders. Here, we have explored the process
of dimerization of human 5-HT4 receptor (h5-HT4R) by means
of co-immunoprecipitation and bioluminescence resonance
energy transfer (BRET). Constitutive h5-HT4(d)R dimer was ob-
served in living cells and membrane preparation of CHO and
HEK293 cells. 5-HT4R ligands did not inﬂuence the constitutive
energy transfer of the h5-HT4(d)R splice variant in intact cells
and isolated plasma membranes. In addition, we found that h5-
HT4(d)R and h5-HT4(g)R which structurally diﬀer in the length
of their C-terminal tails were able to form constitutive heterodi-
mers independently of their activation state. Finally, we found
that coexpression of h5-HT4R and b2-adrenergic receptor
(b2AR) led to their heterodimerization. Given the large number
of h5-HT4R isoforms which are coexpressed in a same tissue,
our results points out the complexity by which this 5-HTR
sub-type mediates its biological eﬀects.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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transfer1. Introduction
The neurotransmitter serotonin (5-hydroxytryptamine, 5-
HT) mediates a wide range of physiological functions by inter-
acting with a large and complex family of receptors [1]. Up to
now 14 diﬀerent 5-HT receptors have been identiﬁed and manyAbbreviations: b2AR, b2-adrenergic receptor; BRET, bioluminescence
resonance energy transfer; CHO, Chinese hamster ovary cells;
DMEM, Dulbeccos modiﬁed Eagles medium; FCS, foetal calf serum;
GPCRs, G protein-coupled receptors; IB, immunoblot; IP, immuno-
precipitation; 5-HT, 5-hydroxytryptamine; HEK293, human embry-
onic kidney 293 cells; h5-HT4R, human 5-HT4 receptor; MT1R, MT1
melatonin receptor; PAGE, polyacrylamide gel electropheris; RLuc,
Renilla luciferase; SDS, sodium dodecyl sulfate; TM, transmembrane;
YFP, yellow ﬂuorescent protein
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implication in various central and peripheral disorders such as
anxiety, depression, dementia, obesity and hypertension [2,3].
They are therefore the purpose of an intensive area of research
for drug discovery.
Preclinical and clinical studies clearly indicate that the 5-
HT4R may represent a valuable target for therapeutic drugs
to treat gastrointestinal diseases and memory disorders [4,5].
But interest in the 5-HT4R also resides in the existence of sev-
eral isoforms expressed in various central and peripheral tis-
sues and their putative role in cell function. The 5-HT4R is
indeed one of the G-protein-coupled receptors (GPCRs) for
which alternative mRNA splicing generates the most variants
that diﬀer in their C-terminal extremities [6]. In human, they
are coded by a single and very complex gene which generates
ten carboxy-terminal splice variants [7–9]. All 5-HT4R iso-
forms share the same ligand binding domain and are positively
coupled to adenylyl cyclase. In contrast to binding studies,
striking diﬀerences in cAMP functional studies were observed
between the pharmacological proﬁle of the h5-HT4R isoforms
[10,11,11–13,13]. Indeed, the eﬃcacy and potency of a given 5-
HT4 ligand may diﬀer from one isoform to another indicating
that the C-terminal tails of h5-HT4R may inﬂuence and con-
tribute to the speciﬁcity of their functional pharmacological
proﬁle [11]. Interestingly, chronic treatment of patients with
bAR antagonists causes 5-HT4R inotropic hyperesponsiveness
in isolated human atrium and myocytes associated with an en-
hanced ability of 5-HT to increase cAMP production [14]. This
observation suggests a cross-talk between 5-HT4R and bAR.
Recently, a large body of biochemical and biophysical evi-
dence indicates that some GPCRs can form homodimers or
heterodimers [15] and that dimer formation can be essential
for some receptor functions as shown for the opioid receptors
[16] and the GABA-B receptor where two receptors are re-
quired to form a functional unit [17]. It is suggested that the
dimerization process may aﬀect the diﬀerent steps of GPCR
life cycle such as receptor maturation, regulation of ligand
binding, receptor signalling and internalization [15]. Given
the potential therapeutic applications of 5-HT4R ligands for
the treatment of many human disorders, it is therefore impor-
tant to determine the dimerization state of h5-HT4R isoforms
as it could have important implications for the development
and screening of drugs targeting this receptor.
To date, there have been no reports providing information
on the dimeric state of 5-HT4R. Here we focused our studyblished by Elsevier B.V. All rights reserved.
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splice variant is of particular interest because it is restricted
to the gut and is only expressed in human. In addition, this
splice variant corresponds to an ultrashort form of the recep-
tor with only two amino acids after the splicing site and is
potently coupled to adenylyl cyclase as compared to other 5-
HT4R isoforms [11,18]. We have used two approaches to
examine the dimeric state of 5-HT4(d)R: the co-immunoprecip-
itation, commonly used for this kind of studies and the biolu-
minescence resonance energy transfer (BRET), more recently
used to monitor protein–protein interactions in living cells
[19]. We also determined the eﬀects of 5-HT4 partial and full
agonists, and neutral antagonists on BRET signals to test
the potential link between receptor activation and dimeriza-
tion. Finally, we investigated the ability of 5-HT4 splice vari-
ants to form heterodimers and dimerize with b2AR since
these receptors are co-expressed in some of their target tissues
[14,20].2. Materials and methods
2.1. Construction of tagged 5-HT4(d)R and 5-HT4(g)R expression
vectors
cDNAs encoding the h5-HT4(d)R and h5-HT4(g)R isoforms [10,18]
were inserted into the mammalian expression vector pcDNA3.1. For
immunoprecipitation studies, receptors were tagged with HA or
FLAG epitopes. h5-HT4R were modiﬁed using a commercial kit
(QuickChange site directed mutagenesis kit, Stratagene) to insert
after the NH2-terminal start methionine, a 9-residue HA epitope
(YPYDVPDYA) and a 8-residue FLAG epitope (DYKDDDDK).
For BRET studies, the Renilla luciferase (RLuc) and the yellow
variant of the green ﬂuorescent protein (YFP) were inserted at the
C-terminal end of the receptor. For this, the same directed mutagen-
esis technique was used to insert an HpaI restriction site just before
the receptor stop codon of h5-HT4(d)R and h5-HT4(g)R isoforms.
Coding region of RLuc and YFP inserted in pcDNA3/CMV vector
were ampliﬁed by PCR to introduce HpaI (just before the ATG in
5 0) and ApaI (just after the stop codon) sites and then, were inserted
in phase with the h5-HT4(d)R or the h5-HT4(g)R at the HpaI/ApaI
cloning sites. DNA sequencing was performed to verify the accuracy
of all fusion constructs. The human MT1 melatonin receptor
fused in frame with either RLuc (MT1R-Rluc) or YFP (MT1R-
YFP) have been previously described [21]. The b2AR fusion protein
constructs b2AR-Rluc and b2AR-YFP have been described else-
where [19].2.2. Cell culture and transient transfection
Chinese hamster ovary (CHO) cells and human embryonic kidney
293 (HEK293) cells were grown at 37 C and 5% CO2 in HamsF12
medium and Dulbeccos modiﬁed Eagles medium (DMEM), respec-
tively, supplemented with 10% (v/v) foetal calf serum, 10 mM
HEPES (pH 7.4) and antibiotics. Transient transfection experiments
were performed using the transfection reagent Jet PEI (poly-plus
transfection, Illkirch, France) according to the manufacturers
instructions. Final concentration of DNA was adjusted to 8 lg per
100 mm Petri dish.2.3. Membrane preparation
Membrane were prepared from cells 48 h after transfection. Brieﬂy,
cells were washed twice with ice-cold PBS. They were then disrupted by
homogenization with a syringe in 500 ll of ice-cold buﬀer A (5 mM
Tris–HCl pH 7.4, 2 mM EDTA, 10 mM iodoacetamide and protease
inhibitor cocktail; Sigma). Lysates were centrifuged at 500 · g for
5 min at 4 C to remove nuclei and unbroken cells. The supernatant
was then centrifuged at 40000 · g for 20 min and the pellet was resus-
pended in buﬀer A and 1% triton ·100 for 1 h at 4 C. The lysate was
centrifuged at 12000 · g for 20 min and then the supernatant was col-
lected for immunoprecipitation.2.4. Immunoprecipitation and Western blotting
Membrane protein samples were precleared by incubation with a
mixture of protein A and G–Sepharose beads (Sigma). After centrifu-
gation, anti-HA antibody (a gift from Jacques Bertoglio, Inserm U-
461, Chaˆtenay-Malabry) or anti-Flag antibody (M2-Flag, Sigma)
was added to the supernatant for 1 h at 4 C. Immunocomplexes were
isolated by incubation with 10% (v/v) protein G–Sepharose (Sigma)
overnight at 4 C. The protein G–Sepharose was washed three times
with buﬀer A and resuspended in 2-fold concentrated Laemmli buﬀer
(125 mM Tris–HCl, pH 6.8, 4% sodium dodecyl sulfate (SDS), 20%
glycerol, 0.01% bromophenol blue) at 60 C for 20 min. Immunocom-
plexes were resolved by 6% SDS–polyacrylamide gel electrophoresis
(PAGE), transferred to a nitrocellulose membrane (Amersham–Phar-
macia Biotech, Orsay, France), and subjected to immunoblotting using
a monoclonal anti-Flag antibody (M2, Sigma). Immunoreactive bands
were then visualized by the ECL detection kit (Amersham–Pharmacia
Biotech, Orsay, France) on Kodak ML lights ﬁlms.
2.5. Cyclic AMP radioimmunoassay
Two days after transfection, CHO cells were cultured overnight in
medium containing 10% dialysed FCS and 4 h before the beginning
of the assay cells were switched to serum-free medium. Then, cells were
preincubated for 15 min with serum-free medium supplemented with
5 mM theophylline, 10 lM pargyline and 1 lM GR127935 to block
the activity of endogenous 5-HT1B receptor [22]. 5-HT4R antagonists
were also added during this preincubation period. 5-HT or other sero-
toninergic agonists were then added for an additional 15 min. The
reaction was stopped by aspiration of the medium and addition of
20% ice-cold perchloric acid. After a 30 min period, neutralization buf-
fer (2 N KOH) was added. The supernatant was extracted after centri-
fugation and then, cAMP was quantiﬁed using a radioimmunoassay
kit (cAMP competitive radioimmunoassay, Immunotech, Marseille).
2.6. Bioluminescence resonance energy transfert (BRET) assay
BRET experiments were performed as previously described [21].
Brieﬂy, 48 h after transfection, CHO or HEK 293 cells (3 · 106 cells/
100 mm dish) expressing h5-HT4R fusion proteins were detached
and washed with PBS. Cell and membrane preparation were distrib-
uted in a 96-well optiplate (Packard) in the presence or absence of li-
gand at 25 C. Coelenterazine h substrate (Molecular Probes,
Eugene, OR) was added at a ﬁnal concentration of 5 lM, and readings
were performed with a lumino/ﬂuorometer Fusion (Packard) which
allows the sequential integration of luminescence signals detected with
two ﬁlter settings (RLuc ﬁlter, 485 ± 10 nm; YFP ﬁlter,
530 ± 12.5 nm). Emission signals at 530 nm were divided by emission
signals at 485 nm. The diﬀerence between this emission ratio obtained
with co-transfected RLuc and YFP fusions proteins and that obtained
with the Luc fusion protein alone was deﬁned as the BRET ratio. Re-
sults were expressed in milliBRET units (mBU, with 1 mBU corre-
sponding to the BRET ratio values multiplied by 1000).3. Results
To study whether the h5-HT4(d)R was able to form stable di-
mers, in a ﬁrst approach we used co-immunoprecipitation
experiments followed by Western blot. CHO cells were co-
transfected with the FLAG epitope-tagged h5-HT4(d)R
(FLAG-h5-HT4(d)R) and HA epitope-tagged h5-HT4(d)R
(HA-h5-HT4(d)R). The polyclonal anti-HA-agarose antibody
was then used to immunoprecipitate the receptor complexes.
As shown in Fig. 1A (lane 3), immunoblot analysis of the pre-
cipitate with the anti-FLAG antibody revealed an immunore-
active band that migrated at a size predicted for a h5-HT4(d)R
dimer (120 kDa). To rule out the possibility that the ob-
served homo-dimerization precipitates were caused by non
speciﬁc aggregation of tagged receptors, extracts from cells
expressing either FLAG-h5-HT4(d)R or HA-h5-HT4(d)R were
mixed, immunoprecipitated with anti-HA agarose and sub-
jected to immunoblot analysis with the anti-FLAG antibody
Fig. 1. Detection of h5-HT4(d)R homodimers by co-immunoprecipitation and BRET experiments. Sequential immunoprecipitation/immunoblot
analysis of CHO (A) and HEK293 (B) cells transfected with the h5-HT4(d)R bearing diﬀerent immunological epitopes. Membrane preparation of a
mixture of cells expressing either the FLAG-h5-HT4(d)R or the HA-h5-HT4(d)R (A, B, lane 2), or cells coexpressing the FLAG-h5-HT4(d)R and the
HA-h5-HT4(d)R (A, B, lane 3), or empty vector transfected (mock) cells (A, B, lane 1) were immunoprecipitated (IP) with the agarose conjugated
anti-HA antibody. The immunoprecipitated proteins were then resolved by non-reducing SDS/PAGE and immunoblotted (IB) with the anti-FLAG
antibody. h5-HT4(d)R dimers can only be seen in cells transfected with FLAG-h5-HT4(d)R and the HA-h5-HT4(d)R (A, B, lane 3). Mock means cells
transfected with the empty vector. The immunoblots shown are representative of at least four independent experiments. (C) Functional activity of h5-
HT4(d)R fusion protein constructs. Cyclic AMP production was measured in CHO cells transfected with the indicated h5-HT4(d)R constructs upon
15 min incubation with 1 lM 5-HT. Values expressed as percentage of control non-stimulated cells are means ± S.E.M. of three experiments
performed in triplicate. BRET signals in cells expressing h5-HT4(g)R-RLuc and h5-HT4(g)R-YFP. Whole cell or membrane preparation from CHO
(D) or HEK293 (E) cells expressing the h5-HT4(d)R-RLuc and the h5-HT4(d)R-YFP receptor at a 1:1 ratio were incubated with 5 lM coelenterazine
and light emission acquisition was performed in a luminometer using RLuc and YFP ﬁlter settings. Results are means ± S.E.M. of three independent
experiments performed in duplicate.
M. Berthouze et al. / FEBS Letters 579 (2005) 2973–2980 2975(Fig. 1A, lane 2). In this case, no band corresponding to h5-
HT4(d)R dimer was detected (Fig. 1A, lane 2). Serotonin 5-
HT4(d)R dimer formation was not restricted to CHO cells since
dimers were also observed in HEK293 cells cotransfected withFLAG-h5-HT4(d)R and HA-h5-HT4(d)R (Fig. 1B, lane 3) but
not in a mix of HEK293 cells expressing either FLAG-h5-
HT4(d)R or HA-h5-HT4(d)R (Fig. 1B, lane 2). No speciﬁc band
migrating at 120 kDa was detected in CHO and HEK cells
Fig. 3. Eﬀect of 5-HT4 ligands on the h5-HT4(d)R dimerization
process. Whole cell or membrane preparation from CHO cells
coexpressing the h5-HT4(d)R-RLuc receptor and the h5-HT4(d)R-
YFP receptor at the ratio 1:1 were incubated with 1 lM 5-HT4R
agonists (5-HT, ML10302, Prucalopride, Renzapride; SB204070) or
1 lM 5-HT4R antagonist (GR113808). Ten minutes after ligand
addition, coelenterazine was added and light emission acquisition was
performed as described in Section 2.
2976 M. Berthouze et al. / FEBS Letters 579 (2005) 2973–2980transfected with the empty vector (mock). Additional bands
detected in h5-HT4R expressing cells (Fig. 1A, B, lane 3) cor-
responded to non-speciﬁc proteins since the same bands were
observed in cells transfected with the empty vector (mock)
(Fig. 1A, B, lane 1).
To study receptor oligomerization in intact cells, we chose
BRET, a technique that has been recently used to monitor pro-
tein–protein interaction [19,21]. The assay relies on the obser-
vation that the degree of physical proximity between molecules
can be assessed in living cells by the level of energy transfer
occurring between the energy donor RLuc and a ﬂuorescent
acceptor, YFP [23]. The h5-HT4(d)R was fused in frame with
either RLuc (h5-HT4(d)R-RLuc) or YFP (h5-HT4(d)R-YFP)
in its C-terminal part. The functionality of the h5-HT4(d)R-
RLuc or h5-HT4(d)R-YFP was assessed by the determination
of cAMP levels produced in transfected CHO cells in response
to 1 lM 5-HT (Fig. 1C). As expected from the positive cou-
pling of the 5-HT4(d)R to adenylyl cyclase, 5-HT induced a
cAMP accumulation in cells transfected with the wild-type
h5-HT4(d)R, and the eﬀect of 5-HT was similar in cells trans-
fected with the h5-HT4(d)R-RLuc or h5-HT4(d)R-YFP con-
structs (Fig. 1C). Moreover, 5-HT (1 lM) also induced a
similar eﬀect in CHO cells expressing the FLAG-h5-HT4(d)R
or HA-h5-HT4(d)R. Thus, the functionality of the fusion pro-
teins used in this study is identical to the wild-type h5-HT4(d)R
(Fig. 1C).
For each BRET experiment, we veriﬁed that the ratio of
YFP ﬂuorescence values and Luc luminescence values (YFP/
Luc), which is indicative of h5-HT4R expression levels, was
identical in all the conditions tested. Coexpression of h5-
HT4(d)R-Rluc and h5-HT4(d)R-YFP resulted in signiﬁcant
energy transfer in membranes of CHO or HEK293 cells indi-
cating that constitutive oligomers exist for the h5-HT4(d)R
(Fig. 1D and E). Similar results were obtained in whole cell
preparation with energy transfer levels very similar to those
observed for the MT1R previously shown to form constitutive
dimers in HEK293 cells (Fig. 2) [21]. In HEK293 cells, the
BRET value between h5-HT4(d)R-Rluc and MT1R-YFP was
close to that observed for h5-HT4(d)R-Rluc and YFP suggest-
ing a background energy transfer between h5-HT4(d)R-RlucFig. 2. Speciﬁcity of the h5-HT4(d)R homodimerization. To assess the speciﬁc
described in Section 2 in membrane preparation from CHO (A) or HEK2
HT4(d)R-YFP, the MT1R-RLuc and the MT1R-YFP, or the h5-HT4(d)R-RLu
in cells transfected with either the h5-HT4(d)R-YFP receptor and the MT1R-R
Results are means ± S.E.M. of three independent experiments performed inand MT1R-YFP (Fig. 2B). The fact that the BRET signal be-
tween h5-HT4(d)R-Rluc and MT1R-YFP or h5-HT4(d)R-YFP
and MT1R-RLuc was higher than that observed for h5-
HT4(d)R-Rluc and YFP in CHO cells can be explained by
the lower BRET values obtained in this cellular system than
in HEK cells (Fig. 2).
As previous studies have shown that ligand binding can reg-
ulate the dimer by promoting or inhibiting its formation [15],
BRET measurements were performed after cell treatments
with h5-HT4(d)R full agonists (5-HT, prucalopride, renza-
pride), partial agonists (ML10302, SB204070) and a neutral
antagonist (GR113808) [11]. CHO cells co-expressing the h5-
HT4(d)R-Rluc and h5-HT4(d)R-YFP were treated for 10 min
at 25 C with a saturating concentration (1 lM) of the respec-
tive 5-HT4R ligands. As shown in Fig. 3, BRET ratios were
not signiﬁcantly diﬀerent for any of the 5-HT4R ligand used
in this study compared to control untreated cells. Shorter or
longer time exposure to the 5-HT4R ligands also did notity of the h5-HT4(d)R homodimerization, BRET signal was measured as
93 (B) cells co-expressing the h5-HT4(d)R-RLuc receptor and the h5-
c receptor and the MT1R-YFP. The BRET signal was also determined
Luc (A) or the h5-HT4(d)R-RLuc receptor and the isolated YFP (A, B).
duplicate.
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(data not shown). In addition, similar results were obtained at
maximal BRET (membrane preparation) and lowBRET (whole
cells) (Fig. 3). Altogether these data indicate that receptor
activation state does not aﬀect oligomerization and, that the
homodimers are most probably constitutively preformed.
Next, we analysed whether the h5-HT4(d)R could dimerize
with a longer h5-HT4 variant, the h5-HT4(g)R isoform which
has 20 amino acids after the splicing site (Fig. 4A). Both recep-
tor isoforms are co-expressed in the gastro-intestinal system
[10,20]. As shown in Fig. 4B (lane 3), the h5-HT4(g)R isoform
was able to form homodimers as detected by immunoprecipi-
tation. No speciﬁc band was observed in immunoprecipitates
prepared from a mixture of HA-h5-HT4(g)R and FLAG-h5-
HT4(g)R expressing cells (Fig. 4B, lane 1). To examine the asso-
ciation between h5-HT4(d)R and h5-HT4(g)R isoforms, we
transiently transfected CHO cells with HA-h5-HT4(d)R and
FLAG-h5-HT4(g)R. When crude membranes were solubilized
with detergent and immunoprecipitated with an anti-HA anti-
body, the anti-FLAG antibody detected a speciﬁc band
migrating at 120 kDa suggesting the formation of h5-
HT4(d)R/h5-HT4(g)R heterodimers (Fig. 4B, lane 4). In con-
trast, no speciﬁc band was observed in immunoprecipitatesFig. 4. Heterodimerization of h5-HT4(d)R and h5-HT4(g)R isoforms. (A) Sch
HT4(d)R and h5-HT4(g)R. h5-HT4R isoforms are identical up to Leu
358. (B) Ch
heterodimers by co-immunoprecipitation. Membrane preparation of a mix
HT4(g)R (lane 1), HA-h5-HT4(d)R or the FLAG-h5-HT4(g)R (lane 2), CHO c
3), or CHO cells coexpressing the HA-h5-HT4(d)R and the FLAG-h5-HT4(g)
anti-HA antibody. The immunoprecipitated proteins were then resolved by n
antibody. Speciﬁc receptor dimers were observed in cells transfected with eith
h5-HT4(d)R and the FLAG-h5-HT4(g)R (lane 4). (C) Functional activity of th
CHO cells transfected with the wild-type h5-HT4(g)R, the h5-HT4(g)R-Rlu
expressed as percentage of control non-stimulated cells are means ± S.E.M. of
and h5-HT4(g)R heterodimers by BRET. Whole cell or membrane prepara
HT4(g)R-YFP, the h5-HT4(d)R-RLuc and the h5-HT4(g)R-YFP, or the h5-
coelenterazine and energy transfer was determined as described in Section 2. R
in duplicate.prepared from a mixture of HA-h5-HT4(d)R and FLAG-h5-
HT4(g)R expressing cells (Fig. 4B, lane 2). These data strongly
suggest that h5-HT4(d)R/h5-HT4(g)R heterodimers pre-existed
in cells prior to cell lysis and were not artiﬁcially formed during
membrane preparation. To conﬁrm the existence of h5-
HT4(g)R homodimers and h5-HT4(d)R/h5-HT4(g)R heterodi-
mers, we next performed BRET experiments. No signiﬁcant
energy transfer was detected in living cells coexpressing h5-
HT4(g)R-RLuc and h5-HT4(g)R-YFP, h5-HT4(g)R-RLuc and
h5-HT4(d)R-YFP, or h5-HT4(d)R-RLuc and h5-HT4(g)R-YFP
(Fig. 4D). Signiﬁcant BRET values were observed for the three
receptor combinations in membranes prepared from these cells
indicating the existence of homo and heterodimers. The fact
that that the energy transfer between h5-HT4(g)R-Rluc and
h5-HT4(d)R-YFP was signiﬁcantly lower than that observed
between h5-HT4(d)R-Rluc and h5-HT4(g)R-YFP suggests that
the C-terminus of the h5-HT4(g) splice variant may inﬂuence
the spatial organization of the Rluc and therefore the BRET
signal (Fig. 4D). All receptor constructs were functional since
the coupling of h5-HT4(g)R-RLuc and h5-HT4(g)R-YFP to
adenylyl cyclase was identical to that of the wild-type
h5-HT4(g)R (Fig. 4C). In addition, expression level of
h5-HT4(g)R-Rluc or h5-HT4(g)R-YFP was similar to theematic representation and C-terminal amino acid sequences of the h5-
aracterization of h5-HT4(g)R homodimers and h5-HT4(d)R/h5-HT4(g)R
ture of CHO cells expressing the HA-h5-HT4(g)R or the FLAG-h5-
ells coexpressing the HA-h5-HT4(g)R and the FLAG-h5-HT4(g)R (lane
R (lane 4), were immunoprecipitated (IP) with the agarose conjugated
on-reducing SDS/PAGE and immunoblotted (IB) with the anti-FLAG
er the HA-h5-HT4(g)R and the FLAG-h5-HT4(g)R (lane 3) or the HA-
e h5-HT4(g)R-YFP fusion protein. cAMP production was measured in
c or the h5-HT4(g)R-YFP upon incubation with 1 lM 5-HT. Values
three experiments performed in triplicate. (D) Detection of h5-HT4(d)R
tion from CHO cells coexpressing the h5-HT4(g)R-RLuc and the h5-
HT4(g)R-RLuc and the h5-HT4(d)R-YFP were incubated with 5 lM
esults are means ± S.E.M. of three independent experiments performed
Fig. 5. Heterodimerization of h5-HT4(d)R and b2AR. (A) Detection of
h5-HT4(d)R and b2AR heterodimers by BRET. Membrane preparation
from CHO cells transfected as indicated with h5-HT4(d)R and/or b2AR
constructs were incubated with 5 lM coelenterazine and energy
transfer was determined as described in Section 2. Results are
means ± S.E.M. of three independent experiments performed in
duplicate. (B) Eﬀect of 5-HT4 and bAR ligands on heterodimer
formation. Membrane preparation from CHO cells expressing the h5-
HT4(d)R-RLuc and the b2AR-YFP at the ratio 1:1 were incubated at
25 C with 1 lM of the diﬀerent ligands. Ten minutes after, BRET was
performed as described in Section 2. Results are means ± S.E.M. of
three independent experiments performed in duplicate. 5-HT (non-
selective 5-HT4R agonist), isoproterenol (non-selective bAR agonist),
GR113808 (5-HT4R antagonist), propranolol (non-selective bAR
antagonist).
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treatment of cells with a saturating concentration of 5-HT4R
ligands did not produce any signiﬁcant change in the BRET ra-
tio in membrane preparation or cell extract (data not shown).
These results indicate that h5-HT4(d)R/h5-HT4(g)R can form
stable heterodimers which are not inﬂuenced by receptor
activation.
Finally, since cross talk between 5-HT4R and b2AR has been
previously observed [14], BRET was measured in CHO cells
transfected with h5-HT4(d)R-RLuc and h5-HT4(d)R-YFP, or
b2AR-RLuc and b2AR-YFP, or b2AR-RLuc and h5-
HT4(d)R-YFP. In accordance with a previous study [19], we
found that b2AR were able to form constitutive homodimers
(Fig. 5A). A signiﬁcant BRET signal was detected in cells
expressing b2AR-RLuc and h5-HT4(d)R-YFP indicating the
formation of b2AR and h5-HT4(d)R heterodimers (Fig. 5A).
This process was not restricted to the h5-HT4(d)R since similar
BRET values were observed in cells transfected with b2AR-
RLuc and h5-HT4(g)R-YFP (data not shown). No signiﬁcant
changes were detected in the measured BRET levels in the
presence of bAR and 5-HT4R ligands (Fig. 5B).4. Discussion
Our data show that the h5-HT4(d)R isoform is able to
form remarkably stable homodimers. This was demonstratedin CHO and HEK293 cells by co-immunoprecipitation/
immunoblot analysis following transfection of diﬀerent
tagged h5-HT4(d)R constructs. A biophysical technique was
used to determine if the h5-HT4(d)R homodimers suggested
by Western blots can be detected in intact living cells co-
expressing h5-HT4(d)R-Rluc and h5-HT4(d)R-YFP fusion
proteins. Co-expression of both receptor constructs resulted
in a positive BRET signal indicating that they are in close
proximity when co-transfected in CHO and HEK293 cells.
Experiments performed on crude membrane preparations
showed a higher BRET signal compared with whole cells.
This is in accordance with a previous study on the dimeriza-
tion of the leptin receptor and suggests that the energy
transfer between the donor and the acceptor may depend
on the environment such as the buﬀer composition and
molecular partners of the receptor [24]. In addition, BRET
values obtained with the h5-HT4(d)R fusion proteins in in-
tact living cells were similar as those observed for the
MT1R [21]. The speciﬁcity of the h5-HT4(d)R dimerization
process eﬀect was demonstrated by a marginal in energy
transfer in cells coexpressing h5-HT4(d)R-Rluc and MT1R-
YFP fusion proteins. Our data also indicate that the h5-
HT4(d)R complexes were pre-existing in the cells and were
not caused by non-speciﬁc aggregation since dimer
formation was only observed from membrane preparation
of cells transfected with both HA-h5-HT4(d)R and FLAG-
5-HT4(d)R and not in mixed preparation of singly transfec-
ted cells.
Interestingly, we found that homodimerization of the h5-
HT4R was not restricted to the short (d) isoform because
this process also occurred at a longer splice variant, the
h5-HT4(g)R isoform which possesses 18 additional amino
acids after the splicing site [10]. The low BRET signal ob-
served with the h5-HT4(g)R-RLuc construct suggests that
the C-terminus of this splice variant may inﬂuence the spa-
tial organization of the Rluc and therefore the intensity of
the energy transfer between the donor and the acceptor. It
is interesting to note that the mouse 5-HT4(e)R splice variant
speciﬁcally binds with its C-terminus to several PDZ-domain
containing proteins [25]. Since the h5-HT4(g)R is very similar
to the mouse 5-HT4(e)R and also contains a canonical recog-
nition motif for PDZ domains at their extreme C-termini
[25], it is therefore likely that the presence of these PDZ-
domain containing proteins in the h5-HT4(g)R modiﬁes the
relative distance and orientation of Rluc and YFP within di-
mers in such a way that no signiﬁcant energy transfer is
detectable. Results obtained in membranes prepared from
these cells support this interpretation since speciﬁc BRET
signals have been observed in these preparations most likely
due to the lost of the PDZ domain containing proteins. Our
co-immunoprecipitation experiments further supported the
existence of h5-HT4(d)R and h5-HT4(g)R heterodimers. These
5-HT4R isoforms were also able to heterodimerize with
b2AR and this strengthens the ﬁnding that 5-HT4R and
b2AR can cross talk in human atria tissues [14]. These
observations raise the question of the molecular determi-
nants involved in homo- and heterodimer formation. The
bulk of literature has centred on the contribution of inter-
molecular hydrophobic interactions between transmembrane
spanning (TM) regions as dimerization interfaces for the
GPCR of family A, which includes the superfamily of 5-HT
receptors. For instance, TM4-TM4 and/or TM4/5-TM4/5
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dopamine D2 receptor [26], rhodopsin [27] and the C5a
receptor [28]. The molecular determinants of 5-HT4R dimer-
ization are currently under investigation.
The documented expression of h5-HT4(d)R and h5-
HT4(g)R isoforms in the gastrointestinal-tract as well as the
coexpression of 5-HT4R and b2AR in human atria myocytes
[14,20], suggests that heterodimers could occur in native tis-
sues. Given the large number of h5-HT4R isoforms which
are coexpressed in a same tissue, one could imagine that het-
erodimerization could be observed with other splice variants
and would represent an extraordinary way to increase the
complexity by which this 5-HT receptor sub-type mediates
its biological eﬀects. However, in contrast to what has been
reported for other GPCRs such as b-adrenergic and opioid
receptors [29], at present it is still unknown whether hetero-
dimer formation may inﬂuence the functional properties of
the splice variants. Some diﬀerences have been noted in 5-
HT4R isoform intrinsic properties such as their constitutive
activity [30], desensitisation process [12], and second messen-
ger production in response to 5-HT4 ligands [11,13,31]. In
addition, as mentioned above, speciﬁc proteins to some 5-
HT4R splice variants associate to their intracellular C-termi-
nal tail [25] and may contribute to the functional speciﬁcity
of the isoforms. Therefore, it is tempting to speculate that
depending on the nature of the 5-HT4R heterodimer, 5-
HT4R functional response may greatly diﬀer from the coex-
pressed and isolated receptors. This attractive hypothesis
may explain the tissue-dependent speciﬁcities observed with
5-HT4 ligands which may act either as partial or full ago-
nists, or antagonists depending on the considered tissue
[4]. However, more information is needed to give clear con-
clusions on the inﬂuence of 5-HT4 homodimer/heterodimer
state on the pharmacological behaviour of the ligands. The
lack of speciﬁc 5-HT4 ligand for each splice variant makes
really diﬃcult to test this hypothesis in native cells and tis-
sues.
The results of our study indicate that 5-HT4R isoforms are
present as constitutive dimers and their homo- or heterodimer-
ized forms are independent of their state of activation by
ligands. Indeed, this is supported by energy transfer experi-
ments showing that the natural agonist, 5-HT and synthetic
agonists such as renzapride, SB204070, ML10302 and prucal-
opride which behave as partial or full agonists at the (d)
variant did not alter the BRET ratio in cells coexpressing
h5-HT4(d)R-Rluc and h5-HT4(d)R-YFP receptors or h5-
HT4(g)R-Rluc and h5-HT4(g)R-YFP receptors. Moreover, the
5-HT4 antagonist, GR113808 did not aﬀect the BRET signal.
It is thus conceivable that neither 5-HT4 agonists nor 5-HT4
antagonists inﬂuence the degree of dimer association/dissocia-
tion. Our results contrast with reports showing that agonists
increase the homo- or heterodimerization of GPCRs such as
adenosine A1 receptors [32]. However, most receptors have
been reported to form constitutive dimers that are not altered
by receptor activation [33].
In summary, immunoprecipitation and BRET experiments
provide evidence for 5-HT4R homo- and heterodimerization
which, is not inﬂuenced by 5-HT4 ligands. We also showed
that 5-HT4R exist as constitutive dimers and form heterodi-
mers with b2AR. Additional studies are required to determine
what is the functional signiﬁcance of dimerization and what
are the molecular determinants involved in this process.Acknowledgements: We thank Monique Gastineau for her excellent
technical assistance. This work was supported by pre-doctoral grants
from the Ministe`re de la Recherche et de lEnseignement Supe´rieur
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